FDA Approves Teva’s Generic Zoloft
This article was originally published in The Pink Sheet Daily
Executive Summary
Teva received FDA final approval for its generic version of Pfizer's antidepressant Zoloft (sertraline) June 30
|
Teva received FDA final approval for its generic version of Pfizer's antidepressant Zoloft (sertraline) June 30. The generic company plans to launch the product in the "latter part of July." Teva holds 180-day marketing exclusivity for the 25 mg, 50 mg and 100 mg versions. Pfizer said it will launch an authorized generic through its Greenstone subsidiary "if and when Zoloft becomes subject to generic competition," (1 (Also see "Pfizer Prepares For Zoloft Authorized Generic Entry Following Teva’s Launch" - Pink Sheet, 29 Jun, 2006.)). |